Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage regimen for administering a CD19XCD3 bispecific antibody

Dosage regimen for administering a CD19XCD3 bispecific antibody

US Patent 8840888 · Granted Sep 23, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody constructs for CDH19 and CD32025
Antibody constructs for DLL3 and CD32025
Anti-CD19 antibodies and multi-specific binding proteins2025
PSMA and CD3 bispecific T cell engaging antibody constructs2025
Multi-specific binding proteins and methods of use thereof2025
Antibody constructs for DLL3 and CD32025
Antibody constructs for CDH19 and CD32025
Cross-species-specific PSMAxCD3 bispecific single chain antibody2025
Binding molecules for BCMA and CD32025
Binding molecules for BCMA and CD32025
Activatable interleukin 12 polypeptides and methods of use thereof2025
Nucleic acids encoding anitbody constructs binding EGFR VIII and CD32024